Evaluating Multisite rCBV Consistency from DSC-MRI Imaging Protocols and Postprocessing Software Across the NCI Quantitative Imaging Network Sites Using a Digital Reference Object (DRO)
Laura C. Bell(University of Pittsburgh), C. Chad Quarles(Barrow Neurological Institute), Bradley J. Erickson(Mayo Clinic), Chengyue Wu(The University of Texas MD Anderson Cancer Center), Thomas L. Chenevert(University of Michigan), Richard L. Wahl(Mallinckrodt (United States)), Anna G. Sorace(University of Alabama at Birmingham), Thomas E. Yankeelov(The University of Texas MD Anderson Cancer Center), Kathleen M. Schmainda(Medical College of Wisconsin), Ananth J. Madhuranthakam(Siemens (Germany)), Jayashree Kalpathy–Cramer(University of Colorado Denver), Marco C. Pinho(The University of Texas Southwestern Medical Center), Mark Muzi(University of Washington), Yi‐Fen Yen(Harvard University), Hongyu An(Okayama University), Panagiotis Korfiatis(Mayo Clinic), Leland Hu(First Affiliated Hospital of Xi'an Jiaotong University), Melissa Prah(S.P.E.C.I.E.S.), Cihat Eldeniz(Washington University in St. Louis), Dariya Malyarenko(University of Michigan), Neal Rutledge(The University of Texas at Austin), Jerrold L. Boxerman(Central South University), Yichu Liu(Chinese Academy of Sciences), Andrew Brenner(The University of Texas at San Antonio Health Science Center), Yuxiang Zhou(Mayo Clinic in Arizona), Andrew Beers(Massachusetts General Hospital), B. Connor Johnson(Southwestern Medical Center), Natenael Semmineh(Barrow Neurological Institute)
Cited by 29
Related Papers
3D Slicer as an image computing platform for the Quantitative Imaging Network
|Magnetic Resonance Imaging|2012|9.1k
The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS)
|IEEE Transactions on Medical Imaging|2014|6.7k
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
|Neuro-Oncology|2015|670
Automated Diagnosis of Plus Disease in Retinopathy of Prematurity Using Deep Convolutional Neural Networks
|JAMA Ophthalmology|2018|660
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
|Journal of Translational Medicine|2018|540